Drugs / Ruyi Jinhuang Powder
Ruyi Jinhuang Powder
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT05638360 | May 2023 → Jun 2025 overdue | — | Changhua Christian Hospital | Recruiting | No outcome recorded |
| Phase 2 | NCT04888234 | May 2021 → Jul 2022 | radiodermatitis | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07712081 | Oct 2023 → Aug 2025 | acute pancreatitis | The Third Affiliated Hospital of Wenzhou Medical University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ru-Yi-Jin-Huang Powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04888234 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Ru-Yi-Jin-Huang Powder is the most common TCM topical drug for skin diseases.” NCT04888234 ↗ |
| Route | Topical | “The treatment group receive topical treatment of Ru-Yi-Jin-Huang Powder.” NCT04888234 ↗ |